355 related articles for article (PubMed ID: 24845547)
1. Disrupting the downward spiral of chronic pain and opioid addiction with mindfulness-oriented recovery enhancement: a review of clinical outcomes and neurocognitive targets.
Garland EL
J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):122-9. PubMed ID: 24845547
[TBL] [Abstract][Full Text] [Related]
2. Treating chronic pain: the need for non-opioid options.
Garland EL
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):545-50. PubMed ID: 24918159
[TBL] [Abstract][Full Text] [Related]
3. The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.
Garland EL; Froeliger B; Zeidan F; Partin K; Howard MO
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2597-607. PubMed ID: 23988582
[TBL] [Abstract][Full Text] [Related]
4. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.
Garland EL; Howard MO; Zubieta JK; Froeliger B
Psychother Psychosom; 2017; 86(2):111-112. PubMed ID: 28183077
[No Abstract] [Full Text] [Related]
5. Mindfulness-oriented recovery enhancement reduces pain attentional bias in chronic pain patients.
Garland EL; Howard MO
Psychother Psychosom; 2013; 82(5):311-8. PubMed ID: 23942276
[TBL] [Abstract][Full Text] [Related]
6. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
[TBL] [Abstract][Full Text] [Related]
7. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
[TBL] [Abstract][Full Text] [Related]
8. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
Sehgal N; Manchikanti L; Smith HS
Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
[TBL] [Abstract][Full Text] [Related]
9. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
Cheatle MD
Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
[TBL] [Abstract][Full Text] [Related]
10. Risk factor assessment for problematic use of opioids for chronic pain.
Jamison RN; Edwards RR
Clin Neuropsychol; 2013; 27(1):60-80. PubMed ID: 22935011
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness-Based Therapy Reduces Chronic Pain and Opioid Misuse.
Slomski A
JAMA; 2022 May; 327(17):1641. PubMed ID: 35503359
[No Abstract] [Full Text] [Related]
12. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
[TBL] [Abstract][Full Text] [Related]
13. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
[TBL] [Abstract][Full Text] [Related]
14. Mindfulness for chronic pain and prescription opioid misuse: novel mechanisms and unresolved issues.
Garland EL; Black DS
Subst Use Misuse; 2014 Apr; 49(5):608-11. PubMed ID: 24611857
[No Abstract] [Full Text] [Related]
15. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature.
Hruschak V; Cochran G; Wasan AD
J Opioid Manag; 2018; 14(5):345-358. PubMed ID: 30387858
[TBL] [Abstract][Full Text] [Related]
17. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
18. Combating the increase in opioid misuse.
Nolan W; Gannon R
Conn Med; 2013 Sep; 77(8):495-8. PubMed ID: 24156180
[No Abstract] [Full Text] [Related]
19. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.
Cheatle MD
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):751-4. PubMed ID: 26933873
[No Abstract] [Full Text] [Related]
20. Variations in prescription opioids and related harms: a key to understanding and effective policy.
Samet JH; Tsui JI
Addiction; 2014 Feb; 109(2):183-5. PubMed ID: 24422611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
